Table 2 Association of ERG expression with clinicopathologic parameters in prostatic acinar adenocarcinoma
From: ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
n (%) | p value | ||||
|---|---|---|---|---|---|
No expression (n = 47) | Low expression (n = 3) | Intermediate expression (n = 10) | High expression (n = 18) | ||
Age group (years) | |||||
40–70 | 30 (63.8) | 0 (0) | 5 (50) | 14 (77.8) | 0.059 |
> 70 | 17 (36.2) | 3 (100) | 5 (50) | 4 (22.2) | |
Total gleason score | |||||
6 | 18 (38.3) | 0 (0) | 1 (10) | 1 (5.6) | 0.009 |
7 | 14 (29.8) | 1 (33.3) | 4 (40) | 4 (22.2) | |
8 | 2 (4.3) | 0 (0) | 2 (20) | 0 (0) | |
9 | 13 (27.7) | 2 (66.7) | 3 (30) | 13 (72.2) | |
Grade | |||||
Grade I | 18 (38.3) | 0 (0) | 1 (10) | 1 (5.6) | 0.008 |
Grade II | 2 (4.3) | 0 (0) | 0 (0) | 2 (11.1) | |
Grade III | 12 (25.5) | 1 (33.3) | 4 (40) | 2 (11.1) | |
Grade IV | 2 (4.3) | 0 (0) | 2 (20) | 0 (0) | |
Grade V | 13 (27.7) | 2 (66.7) | 3 (30) | 13 (72.2) | |
Tumor quantification | |||||
< 10 | 10 (21.3) | 0 (0) | 0 (0) | 1 (5.6) | 0.398 |
10–50 | 14 (29.8) | 0 (0) | 3 (30) | 7 (38.9) | |
> 50 | 23 (48.9) | 3 (100) | 7 (70) | 10 (55.6) | |
Perineural invasion | |||||
Present | 10 (21.3) | 1 (33.3) | 6 (60) | 8 (44.4) | 0.043 |
Absent | 37 (78.7) | 2 (66.7) | 4 (40) | 10 (55.6) | |
Lymphovascular invasion | |||||
Present | 1 (2.1) | 0 (0) | 0 (0) | 0 (0) | 1.000 |
Absent | 46 (97.9) | 3 (100) | 10 (100) | 18 (100) | |
Extraprostatic extension | |||||
Present | 2 (4.3) | 0 (0) | 0 (0) | 3 (16.7) | 0.357 |
Absent | 45 (95.7) | 3 (100) | 10 (100) | 15 (83.3) | |
Seminal vesicle invasion | |||||
Present | 2 (4.3) | 0 (0) | 0 (0) | 2 (11.1) | 0.534 |
Absent | 45 (95.7) | 3 (100) | 10 (100) | 16 (88.9) | |